Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seah H Lim

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Journal of Translational Medicine|February 3, 2017
Opening editorialSeah H Lim
Biomarker Research|August 21, 2020
Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventionsDibyendu Dutta, Seah H Lim
American Journal of Hematology|April 4, 2020
Clinicopathologic consequences following discontinuation of rifaximin in patients with sickle cell diseaseSeah H Lim, Dibyendu Dutta
Medicina (Kaunas, Lithuania)|October 26, 2024
GBT1118, a Voxelotor Analog, Ameliorates Hepatopathy in Sickle Cell DiseaseElio Haroun, Seah H Lim, Dibyendu Dutta
Leukemia Research|July 22, 2008
Early renal arterial stent thrombosis associated with the JAK2 V617F mutationPiotr Tabaczewski, Suhasini Nadesan, Seah H Lim
American Journal of Blood Research|March 21, 2012
Cancer-testis antigens: the current status on antigen regulation and potential clinical useSeah H Lim, Yana Zhang, Jian Zhang
Journal of Translational Medicine|December 2, 2016
Sickle cell vaso-occlusive crisis: it's a gut feelingSeah H Lim, Loren Fast, Alison Morris
American Journal of Hematology|September 13, 2019
Rifaximin for sickle cell diseaseSeah H Lim, Dibyendu Dutta, Judy Moore
Leukemia Research|October 14, 2008
Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: a common defective stem cell?Piotr Tabaczewski, Sushani Nadesan, Seah H Lim
British Journal of Haematology|April 13, 2023
Effects of GBT1118, a voxelotor analog, on intestinal pathophysiology in sickle cell diseaseElio Haroun, Dibyendu Dutta, Seah H Lim
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Journal of Translational Medicine|February 3, 2017
Opening editorialSeah H Lim
Biomarker Research|August 21, 2020
Bidirectional interaction between intestinal microbiome and cancer: opportunities for therapeutic interventionsDibyendu Dutta, Seah H Lim
American Journal of Hematology|April 4, 2020
Clinicopathologic consequences following discontinuation of rifaximin in patients with sickle cell diseaseSeah H Lim, Dibyendu Dutta
Medicina (Kaunas, Lithuania)|October 26, 2024
GBT1118, a Voxelotor Analog, Ameliorates Hepatopathy in Sickle Cell DiseaseElio Haroun, Seah H Lim, Dibyendu Dutta
Leukemia Research|July 22, 2008
Early renal arterial stent thrombosis associated with the JAK2 V617F mutationPiotr Tabaczewski, Suhasini Nadesan, Seah H Lim
American Journal of Blood Research|March 21, 2012
Cancer-testis antigens: the current status on antigen regulation and potential clinical useSeah H Lim, Yana Zhang, Jian Zhang
Journal of Translational Medicine|December 2, 2016
Sickle cell vaso-occlusive crisis: it's a gut feelingSeah H Lim, Loren Fast, Alison Morris
American Journal of Hematology|September 13, 2019
Rifaximin for sickle cell diseaseSeah H Lim, Dibyendu Dutta, Judy Moore
Leukemia Research|October 14, 2008
Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: a common defective stem cell?Piotr Tabaczewski, Sushani Nadesan, Seah H Lim
British Journal of Haematology|April 13, 2023
Effects of GBT1118, a voxelotor analog, on intestinal pathophysiology in sickle cell diseaseElio Haroun, Dibyendu Dutta, Seah H Lim
Pageof 11